E
$190–255K / year · Remote · United States
Erasca
Erasca is a clinical-stage precision oncology company, founded in 2018, developing modality-agnostic therapies that target the RAS/MAPK signalling pathway across a range of cancers.
1 job
Erasca is a clinical-stage precision oncology company, founded in 2018, developing modality-agnostic therapies that target the RAS/MAPK signalling pathway across a range of cancers.
1 job